The gram-positive organism Micrococcus luteus (formerly Micrococcus lysodeikticus) was initially isolated from the nasal secretion of a patient with acute coryza (6) . Human skin is considered to be a primary habitat of the bacterium, and it has also been detected in the mucous membranes as well as in water and soil (18) . Recently, this organism was recognized as an opportunistic pathogen and has been implicated in recurrent bacteremia (29, 44) , septic shock (3), septic arthritis (45) , endocarditis (5, 10, 35) , meningitis (7), intracranial suppuration (36) , and cavitating pneumonia in immunosuppressed patients (38) .
We found that M. luteus cells and cell walls induced serum cytokines in muramyldipeptide-primed mice (24) . M. luteus cell walls consist of two polymers, i.e., peptidoglycans (9, 33) and teichuronic acids (TUA) (14, 26, 30) , which are composed of N-acetyl-D-mannosaminuronic acid and D-glucose residues covalently bonded to each other (Fig. 1) . Unlike the usual peptidoglycans from various gram-positive bacteria, those from M. luteus lacked immunomodulating activities such as immunoadjuvant activity (19) , antitumor activity (11) , mitogenic activity (12) , and cytokine-inducing activity (21) . We showed that the cytokine-inducing activity of M. luteus cell walls was attributable to the TUA portion and not to the peptidoglycan portion (25) . Furthermore, the activity of TUA was detected in an in vivo experiment using C3H/HeN mice and in peritoneal macrophage cultures from C3H/HeN mice but not from C3H/HeJ mice (25) .
C3H/HeJ mice are genetically resistant to the immunobiological activities of lipopolysaccharides (LPS) (39) . Recent studies indicated that a missense mutation in the third exon of the Toll-like receptor 4 (TLR4) gene in C3H/HeJ mice, which replaced proline with histidine at position 712 of TLR4, rendered the mice resistant to endotoxin (31, 32) . Akira's group (16, 40, 41) then demonstrated that TLR2 was essential for the responses to peptidoglycans and lipopeptide, while TLR4 was essential for the responses to lipoteichoic acid as well as to LPS, in peritoneal macrophage cultures from TLR2 and TLR4 knockout mice.
In the present study, we first examined whether M. luteus TUA activated murine and human monocytic cells. We then examined the possible involvement of CD14 and TLR4 in the responses of the cells to TUA, which are similar to those to LPS.
MATERIALS AND METHODS
Reagents. Purified TUA (p-TUA) were prepared from M. luteus NCTC 2665 as described previously (14) . Briefly, the cell walls from stationary-phase M. luteus cells were digested with egg white lysozyme and L 11 enzyme and then fractionated through an ECTEOLA-cellulose column. To obtain TUA with aminohexose residues (p-TUA-[H]) instead of the original aminohexuronic acid residues, p-TUA was acetylated with acetic anhydride, reduced with diborane, and treated with mild alkali to remove O-acetyl groups. The structures of p-TUA and p-TUA- [H] are shown in Fig. 1 . The possible contaminating LPS contents in p-TUA and p-TUA-[H] were calculated as 0.091 and 0.070 ng/mg, respectively, based on the results of the colorimetric Limulus test using Escherichia coli O111:B4 LPS as a control (25) . Ultrapurified LPS prepared from Salmonella choleraesuis subsp. choleraesuis serovar Abortus-equi (Novo-Pyrexal) (8), a gift from C. Galanos (Max Planck Institut für Immunbiologie, Freiburg, Germany), was used as reference LPS. A synthetic lipid A precursor IV A (LA-14-PP or compound 406) was obtained from Daiichi Chemical Co. (Tokyo, Japan), and an anti-mouse CD14 monoclonal antibody (MAb) (4C1; rat immunoglobulin G2b [IgG2b]) was prepared as described previously (1) . The isotype-matched rat IgG2b, anti-human CD14 MAb MY4, and isotype-matched mouse IgG2b were obtained from Coulter Co., (Miami, Fla). Anti-human TLR4 MAb HTA125 was prepared as described previously (37) . Unless otherwise indicated, other reagents were purchased from Sigma Chemical Co. statistical significance of differences between each test group and its respective control was examined by Student's t test.
RESULTS

Expression of mCD14 by J774.1 and LR-9 cells in culture.
LR-9 cells were originally isolated from J774.1 cells as an LPS-resistant mutant with a defect in LPS binding (13) and later were reported to lack mCD14 (27) . Therefore, we first compared mCD14 expression by J774.1 cells with that by LR-9 cells by flow cytometry. The J774.1 cells were clearly stained with anti-mouse CD14 MAb, whereas LR-9 cells were only weakly stained (Fig. 2) . These results indicated that the parent J774.1 and the mutant LR-9 cells express mCD14 at high and low levels, respectively.
Induction of TNF-␣ production by p-TUA in J774.1 and LR-9 cells in culture. First, we examined the potency of p-TUA to induce TNF-␣ production in J774.1 and LR-9 cells in culture. In J774.1 cells, p-TUA exhibited a definite activity to induce TNF-␣ release in a concentration-dependent manner from 1 to 100 g/ml (Fig. 3A) . In the same experiment, the reference LPS induced TNF-␣ production in a concentration-dependent manner from 1 to 100 ng/ml and exhibited a plateau response at 100 ng/ml to 10 g/ml. In accordance with a previous report by Nishijima et al. (27) , LR-9 cells did not respond to the lower concentrations of LPS (1 to 100 ng/ml) and showed only a slight response to the higher concentrations (1 and 10 g/ml) (Fig. 3B) . In LR-9 cell cultures, p-TUA showed almost no ability to induce TNF-␣; no activity was seen 1 ng/ml to 50 g/ml, and slight but negligible activity was observed at 100 g/ml. In contrast, both J774.1 and LR-9 cells responded to a CD14-independent stimulant, phorbol myristate acetate, to similar extents (Fig. 4) . These findings strongly suggested that p-TUA activates J774.1 cells preferentially in an mCD14-dependent manner.
Blocking effect of anti-mouse CD14 MAb on TNF-␣ secretion by J774.1 cells in response to p-TUA. To further determine whether p-TUA activated J774.1 cells in an mCD14-dependent manner, J774.1 cells were preincubated with anti-mouse CD14 MAb 4C1 (50 g/ml) for 30 min and then stimulated with p-TUA (50 g/ml) or reference LPS (10 ng/ml) for 24 h. Pretreatment of J774.1 cells with the anti-mouse CD14 MAb almost completely inhibited the p-TUA-induced TNF-␣ release (Fig. 5) . In accordance with the results shown in Fig. 3 , the blocking effect of the MAb on TNF-␣ release induced by p-TUA was observed more clearly than that induced by the reference LPS. These findings We further examined the cytokine-inducing activity of p-TUA in OCT-differentiated human monocytic THP-1 cells. p-TUA induced IL-8 in a concentration-dependent manner from 1 to 100 g/ml in the THP-1 cells. The maximum IL-8 level induced by p-TUA (100 g/ml) was comparable to that induced by reference LPS (0.01 to 10 g/ml), although considerably higher concentrations of p-TUA were required to exert sufficient activity compared with LPS (Fig. 6) .
Blocking effect of anti-human CD14 MAb on IL-8 secretion by THP-1 cells in response to p-TUA. To determine whether p-TUA also activated THP-1 cells in a CD14-dependent manner, OCTdifferentiated THP-1 cells were preincubated with anti-human CD14 MAb MY4 (10 g/ml) or isotype-matched antibody (IgG2b) for 30 min and then stimulated with p-TUA (50 g/ml) or reference LPS (10 ng/ml). Pretreatment of the THP-1 cells with anti-human CD14 MAb inhibited IL-8 production induced by p-TUA to almost the same level as observed with medium alone (Fig. 7) . This result suggested that p-TUA activated OCTdifferentiated THP-1 cells in a CD14 (probably mCD14)-dependent manner similarly to LPS.
Blocking effect of anti-TLR4 MAb on IL-8 secretion by THP-1 cells in response to p-TUA. Next, we examined whether TLR4 is involved in IL-8 production by THP-1 cells in response to p-TUA similarly to LPS. OCT-treated THP-1 cells were preincubated with anti-human TLR4 MAb HTA125 (5 g/ml) or isotype-matched antibody IgG2a for 30 min and then stimulated with p-TUA (50 g/ml) or reference LPS (10 ng/ ml). The IL-8 release induced by p-TUA was markedly inhibited by HTA125 to an extent similar to that for LPS (Fig. 8) . This result suggested that p-TUA activated THP-1 cells in the same (i.e., TLR4-dependent) manner as LPS.
Inhibitory effect of LA-14-PP on IL-8 secretion by THP-1 cells in response to p-TUA. LA-14-PP is an endotoxin antagonist in human cells and has been suggested to antagonize LPS at multiple sites in the LPS recognition pathway (17, 22) . Therefore, we examined the possible antagonistic effects of LA-14-PP against p-TUA in OCT-differentiated THP-1 cells. The IL-8 release induced by p-TUA was markedly inhibited by LA-14-PP in a concentration-dependent manner (Fig. 9) . Complete inhibition was observed at 10 g of LA-14-PP per ml versus 50 g of p-TUA per ml and at 1 g LA-14-PP versus 10 ng of LPS per ml.
Inactivity of p-TUA-[H] in both J774.1 and THP-1 cells. The above findings suggested that the receptor system is shared by p-TUA and LPS, i.e., is mCD14 and TLR4 dependent. As mentioned in Materials and Methods, the Limulus test suggested that the p-TUA preparations might have been slightly contaminated with LPS (0.091 ng/mg). To exclude the possibility that the activities of p-TUA were due to contaminating LPS in the preparation, the activity of the Fig. 10A ) and THP-1 (Fig.  10B ) cells in culture. These results support the conclusion that the activities of p-TUA were inherent and not attributable to contaminating LPS in the p-TUA preparations.
DISCUSSION
In this study, we demonstrated that the cell wall TUA from the gram-positive organism M. luteus activated human monocytic THP-1 cells in a CD14-and TLR4-dependent manner and that the TUA also activated murine monocytic J774.1 cells in a CD14-dependent manner. CD14 is known to be a pattern recognition molecule and to recognize common structures on various bacterial cell surfaces (43) . The TUA is a special structure of the M. luteus cell wall, and therefore this finding is clear evidence that this special structure is also recognized by CD14. TLR4 is involved mainly in recognition of gram-negative bacteria, probably through recognition of the LPS portion, while TLR2 is involved mainly in recognition of gram-positive bacteria, probably through recognition of the peptidoglycan portion (2, 23, 42) . However, this is not necessarily the case, because (i) peptidoglycans, which are recognized by TLR2 (34, 40, 46) , are distributed ubiquitously in both gram-positive and gram-negative bacteria, although their contents in the cell wall are high and low, respectively; (ii) another ubiquitous component, lipoprotein (or lipopeptide), which frequently coexists with LPS as endotoxin protein, is recognized by TLR2 (15, 41) ; and (iii) lipoteichoic acid, which is widely distributed in gram-positive bacteria, is recognized by TLR4 (40), although the converse result was also reported (34) . This is the first report of a TLR4-recognized chemically defined cell surface component prepared from gram-positive bacteria. Furthermore, immunobiological activities of this bacterium are attributable mainly to TUA (25) , because peptidoglycans of this bacterium lacked bioactivities, as described above. Thus, it is possible that whole cells of this gram-positive bacterium might be recognized by TLR4, not by TLR2, unlike the case for most gram-positive bacteria. Further experiments to investigate this possibility using various micrococcal cells and cell walls are in progress.
The possible unique recognition system for M. luteus might be of some advantage for the bacterium to colonize tissues by escaping from the innate immune system of the host. Hosts carrying TLR4 mutations (4) might be sensitive to infection by M. luteus as well as gram-negative bacteria. Furthermore, hosts in a state of endotoxin tolerance, where function of TLR4 is down-regulated (28), probably to avoid harmful effects of endotoxic activity, would be easily infected with M. luteus.
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